User Name Password

back to homepage

London Capital (LCG.L) - forecasts and valuation increased
LCG.L
Full Report by Objective Capital , Jun 19, 2008 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • Capital Spreads grew faster than expected in 2007 and continues to do so in 2008, with growth accelerating due to the white label partnerships signed last year. Capital Spreads had a robust first quarter and is performing ahead of management expectations.

  • Capital Forex grew its revenues almost threefold in 2007 and client funds on deposit grew 158%. While the average ticket size has fallen back since 2007 Q1, the number of clients and the number of trades has continued to grow each quarter. The AGM statement confirms continued robust growth in the first quarter of 2008.

  • With a lean, low cost business model and modest capital requirements London Capital continues to have a very high rate of cash conversion. Cash on hand increased nearly threefold in 2007.

  • London Capital increased its dividend for 2007 to a total of 6.5p per share from 1.7p in 2006. Given the company’s modest capital requirements, its low risk business model and its preferred route of growing its businesses organically, we expect the dividend pay-out ratio to reflect the earnings, cashflow and potential of the group.

  • Upwards revision of our forecasts. The faster than expected growth of the business, its cash generation and its continued robust growth (see AGM statement 23rd April) have resulted in an upwards revision of our forecasts and in our valuation. Our core scenario valuation has increased from 301p to 458p per share.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer